Combination Treatment of Gemcitabine and Sorafenib Exerts a Synergistic Inhibitory Effect on Non‑small Cell Lung Cancer In�vitro and In�vivo via the Epithelial‑to‑mesenchymal Transition Process
Oncology Letters - Greece
doi 10.3892/ol.2020.11536
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2020
Authors
Publisher
Spandidos Publications